BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12593852)

  • 1. Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin.
    Wang JH; Nie HL; Huang H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2003 Feb; 302(1):89-94. PubMed ID: 12593852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity.
    Wang JH; Nie HL; Tam SC; Huang H; Zheng YT
    FEBS Lett; 2002 Nov; 531(2):295-8. PubMed ID: 12417329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin.
    Ouyang DY; Chan H; Wang YY; Huang H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2006 Jan; 339(1):25-9. PubMed ID: 16289100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro.
    Wang JH; Tam SC; Huang H; Ouyang DY; Wang YY; Zheng YT
    Biochem Biophys Res Commun; 2004 May; 317(4):965-71. PubMed ID: 15094363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the antigenic determinants and reducing the immunogenicity of trichosanthin by site-directed mutagenesis.
    An Q; Wei S; Mu S; Zhang X; Lei Y; Zhang W; Jia N; Cheng X; Fan A; Li Z; Xu Z
    J Biomed Sci; 2006 Sep; 13(5):637-43. PubMed ID: 16977428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position 120-123, a potential active site of trichosanthin.
    Nie H; Cai X; He X; Xu L; Ke X; Ke Y; Tam SC
    Life Sci; 1998; 62(6):491-500. PubMed ID: 9464461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation.
    He XH; Shaw PC; Tam SC
    Life Sci; 1999; 65(4):355-68. PubMed ID: 10421422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced apoptotic action of trichosanthin in HIV-1 infected cells.
    Wang YY; Ouyang DY; Huang H; Chan H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1075-80. PubMed ID: 15882987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichosanthin inhibits integration of human immunodeficiency virus type 1 through depurinating the long-terminal repeats.
    Zhao WL; Feng D; Wu J; Sui SF
    Mol Biol Rep; 2010 Apr; 37(4):2093-8. PubMed ID: 19669933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.
    An Q; Lei Y; Jia N; Zhang X; Bai Y; Yi J; Chen R; Xia A; Yang J; Wei S; Cheng X; Fan A; Mu S; Xu Z
    Biomol Eng; 2007 Dec; 24(6):643-9. PubMed ID: 18023612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses.
    Chan DS; Chu LO; Lee KM; Too PH; Ma KW; Sze KH; Zhu G; Shaw PC; Wong KB
    Nucleic Acids Res; 2007; 35(5):1660-72. PubMed ID: 17308345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/function relationship study of Tyr14 and Arg22 in trichosanthin, a ribosome-inactivating protein.
    Shaw PC; Mulot S; Ma SK; Xu QF; Yao HB; Wu S; Lu XH; Dong YC
    Eur J Biochem; 1997 Apr; 245(2):423-7. PubMed ID: 9151974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors.
    Zhao J; Ben LH; Wu YL; Hu W; Ling K; Xin SM; Nie HL; Ma L; Pei G
    J Exp Med; 1999 Jul; 190(1):101-11. PubMed ID: 10429674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the anti-herpetic effect of trichosanthin by acyclovir and interferon.
    Zheng YT; Chan WL; Chan P; Huang H; Tam SC
    FEBS Lett; 2001 May; 496(2-3):139-42. PubMed ID: 11356198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of trichosanthin-induced CD95 (Fas) type I into type II apoptotic signaling during Herpes simplex virus infection.
    He D; Yau K; He X; Shi H; Zheng Y; Tam S
    Mol Immunol; 2011 Sep; 48(15-16):2000-8. PubMed ID: 21723610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase.
    Au TK; Collins RA; Lam TL; Ng TB; Fong WP; Wan DC
    FEBS Lett; 2000 Apr; 471(2-3):169-72. PubMed ID: 10767416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells.
    Huang H; Chan H; Wang YY; Ouyang DY; Zheng YT; Tam SC
    Life Sci; 2006 Aug; 79(13):1287-92. PubMed ID: 16725160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and DNA sequence of a gene encoding alpha-trichosanthin, a type I ribosome-inactivating protein.
    Chow TP; Feldman RA; Lovett M; Piatak M
    J Biol Chem; 1990 May; 265(15):8670-4. PubMed ID: 2341400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.
    Shi WW; Wong KB; Shaw PC
    Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30127254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells.
    Lee-Huang S; Huang PL; Kung HF; Li BQ; Huang PL; Huang P; Huang HI; Chen HC
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6570-4. PubMed ID: 1713684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.